Answers are grounded in this paper and cite their sources.
Epigenetic mechanisms are known to be involved in tissue-specific differentiation. DNA methylation patterns have shown to be largely conserved across tissues but with variation for specific genes. However, it is unclear the variability observed in the methylation profile of a metabolically active tissue is reflected in other sources as hematopoietic tissue. This study aimed to test blood genome-wide CpG site methylation levels as a model for visceral adipose tissue (VAT) methylation and to verify whether it appropriately reflects in methylation levels found in VAT between men discordant for the metabolic syndrome (MetS). Tissue (VAT and blood samples) were obtained from 16 severely obese individuals discordant for the MetS. sites methylation levels were measured with the Infinium HumanMethylation450 BeadChip and correlations of levels between VAT and blood were computed. Differences in methylation levels between individuals and without MetS were tested in both tissues. Pathway analysis was conducted for differentially methylated sites common to both tissues. High cross-tissue correlations were observed for VAT and blood (0.952±0.014) some CpG sites had significantly different methylation levels in VAT versus blood. Differential methylation between individuals with and without MetS demonstrated a higher number of differentially methylated CpG in VAT than in blood (11,778 vs. 881, respectively) with nearly 4% of differentially methylated sites found in VAT also represented in blood. Common differentially methylated sites were involved in inflammatory-, lipid- and -related pathways. These results suggest that blood methylation levels of specific CpG sites may reflect VAT methylation levels for some of the MetS-related genes, specifically for inflammatory, lipid and metabolism genes.
No takes yet. Share an insight, caveat, or question.
Guénard et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: